Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | EGFR | P00533 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL607857 | 0.87 | ALDH1A1 (0.41) | EGFR | |
| SCHEMBL25906795 | 0.86 | CA1 (0.35) | CA1CA2 | |
| SCHEMBL12301913 | 0.82 | ALDH1A1 (0.33) | CA1CA2SMN1; SMN2 | |
| SCHEMBL2893566 | 0.79 | SLC13A3 (0.38) | CA1CA2SMN1; SMN2 | |
| SCHEMBL16482858 | 0.79 | TET2 (0.35) | EGFR | |
| SCHEMBL47896 | 0.79 | SMN1; SMN2 (0.41) | CA1CA2SMN1; SMN2 | |
| SCHEMBL15085760 | 0.79 | CA1 (0.33) | CA1CA2 | |
| SCHEMBL14213757 | 0.79 | POLB (0.34) | — | |
| SCHEMBL6429925 | 0.78 | MGAM (0.46) | EGFR | |
| SCHEMBL5965099 | 0.77 | ALDH1A1 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080161394-A1 | Cosmetic composition comprising at least one volatile carbonic acid ester | L'OREAL S.A. (FR) | 2008-07-03 | — | — | US | claimed |
| US-20140081012-A1 | NANOPARTICLE, LIPOSOMES, POLYMERS, AGENTS AND PROTEINS MODIFIED WITH REVERSIBLE LINKERS | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2014-03-20 | — | — | US | disclosed |
| US-20080161394-A1 | Cosmetic composition comprising at least one volatile carbonic acid ester | L'OREAL S.A. (FR) | 2008-07-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140081012-A1 | NANOPARTICLE, LIPOSOMES, POLYMERS, AGENTS AND PROTEINS MODIFIED WITH REVERSIBLE LINKERS | HLCS, LNPK, LNPEP | CA1 3480/4885CA2 4339/4885EGFR 790/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.